A Phase I Study Using Most Closely HLA-matched Adenovirus-specific T Lymphocytes for the Treatment of Adenovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-A)
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 05 Aug 2017
At a glance
- Drugs Adenovirus specific T cells ViraCyte (Primary)
- Indications Adenovirus infections
- Focus Adverse reactions
- Acronyms VIRALYM-A
- Sponsors ViraCyte
- 27 Jul 2017 Planned initiation date changed from 1 Aug 2017 to 1 Sep 2017.
- 24 Jul 2017 Planned initiation date changed from 1 Jan 2016 to 1 Aug 2017.
- 21 Feb 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.